Aster Insights has announced its participation as a research partner at the American Society of Clinical Oncology (ASCO) Annual Meeting June 2-6, 2023, in Chicago. An oral presentation and three posters will be presented at this year’s ASCO meeting, utilizing the lifetime patient-consented longitudinal clinicogenomic...
Evidation and Myovant Sciences conducted a survey about the lived experiences of people with endometriosis and/or uterine fibroids. The results of that survey show the magnitude of the negative impacts these conditions have on employee and student experiences and quality of life and indicate a...
Results from the 12-month, multicenter, observational study, WATCH-PD, were recently published in the journal Nature. The researchers found significant associations between digital biomarkers with a wearable device and conventional clinical scoring methods used in Parkinson’s disease (PD). Working with Clinical Ink to gather the real-world...
Replica Analytics, an Aetion company, is partnering with data privacy software solutions developer Private AI. The partnership is a response to an urgent need for a privacy-preserving solution in healthcare and aims to provide a comprehensive solution for healthcare’s data privacy and security challenges. Replica Analytics’...
Aster Insights has announced the appointment of Dr. Anand Shah as chief executive officer, effective immediately. He succeeds Jim Gabriele, who has stepped down from his position. Gabriele and Shah have collaborated closely on a number of strategic, operational, and business development initiatives over the...
Komodo Health has recently launched MapEnhance, a feature that leverages a network of specialty data partners connecting into the company’s platform. MapEnhance builds on Komodo’s Healthcare Map, which it characterizes as a de-identified data set on 330 million patients in the United States, by combining it...
Twist Bioscience Corporation, a company that offers high-quality synthetic DNA using its silicon platform, along with Aster Insights, has announced the availability of the AsterExome panel, which can simultaneously enable whole exome sequencing (WES) with additional coverage for target regions known to contain 620 genes...
Clinical Ink, a global life science technology company, now offers continuous glucose monitoring (CGM) within its integrated digital biomarker solution. The new modules enable remote collection, central storage, and analysis of sensor data from commercially available devices for use in diabetes clinical trials. The solution...
Real-world evidence (RWE) technology and analytics company Aetion has announced the culmination of the RCT-DUPLICATE demonstration project, with complete findings published in The Journal of the American Medical Association (JAMA). This three-year initiative tested whether researchers asking clinical questions in real-world data (RWD)—data from patients’...
In a recent episode of the PharmaPhorum podcast, Evidation co-CEO and Executive Chair of the Board Deborah Kilpatrick discussed healthcare data collection in 2023 and how it intersects with stakeholders across the ecosystem, from tech and pharma companies to research participants. The discussion began with data...